Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1

Christian C Dibble1, John M Asara, Brendan D Manning

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, 665 Huntington Ave., SPH2-117, Boston, MA 02115, USA.

Insights

Researchers identified a key phosphorylation site on Rictor (T1135) regulated by mTORC1. This finding sheds light on the signaling mechanisms controlling mTORC2 activity and Akt phosphorylation, crucial for cell growth and metabolism.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Biochemistry

Background:

  • The mammalian target of rapamycin (mTOR) pathway is critical for cell growth, proliferation, survival, and metabolism.
  • mTOR functions in two complexes, mTORC1 and mTORC2, with mTORC1 regulation well-understood but mTORC2 regulation less defined.

Purpose of the Study:

  • To elucidate the signaling mechanisms regulating mTORC2.
  • To identify and characterize novel regulatory phosphorylation sites on Rictor, a core component of mTORC2.

Main Methods:

  • Liquid chromatography-tandem mass spectrometry to identify phosphorylation sites on Rictor.
  • Site-directed mutagenesis to create Rictor phosphorylation site mutants (T1135A).
  • Cellular assays in wild-type and Rictor null cells to assess effects on Akt, SGK1, and PKC alpha phosphorylation.

Main Results:

  • Identified 21 phosphorylation sites on Rictor, including T1135, which is growth factor-responsive and rapamycin-sensitive.
  • Rictor-T1135 is phosphorylated by the mTORC1-dependent kinase S6K1.
  • Phosphorylation of Rictor-T1135 increases mTORC2-dependent Akt S473 phosphorylation and stimulates Rictor binding to 14-3-3 proteins, acting in parallel with other feedback mechanisms.

Conclusions:

  • Rictor T1135 phosphorylation by S6K1 is a novel regulatory mechanism for mTORC2.
  • This phosphorylation event influences Akt activation by insulin, independent of mTORC2 integrity or kinase activity.
  • The findings reveal a new layer of crosstalk between mTORC1 and mTORC2, impacting cellular metabolism and growth signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...